Citius Pharmaceuticals Inc (CTXR)

[ALERTS100%to10000%GAIN]

CTXR~~SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table shows the amount of our common stock beneficially owned as of November 30, 2018 by (i) each person or group as those terms are used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), believed by us to beneficially own more than 5% of our common stock, (ii) each of our directors, (iii) each of our named executive officers, and (iv) all of our directors and named executive officers as a group. Except as otherwise noted, each person named in the table has sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.

Name of Beneficial Owner (1)

Number of
Shares of
Common Stock
Beneficially
Owned
(2)


Percentage of
Shares of
Common
Stock
Beneficially
Owned
(3)








Executive Officers and Directors






Myron Holubiak (4)


2,152,569



11.54
%
Leonard Mazur (5)


11,077,506



50.30
%
Jaime Bartushak (6)


113,027



*

Suren Dutia (7)


36,667



*

Dr. William Kane (8)


35,405



*

Howard Safir (8)


35,405



*

Carol Webb (8)


35,405



*

Eugene Holuka (9)


25,749



*

All executive officers and directors as a group (8 people)


13,511,730



58.52
%









Other 5% holders








Armistice Capital, LLC(10)


1,797,866



9.99
%